Aledort LM - Search Results

1

Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP).

Gernsheimer TB, George JN, Aledort LM, Tarantino MD, Sunkara U, Matthew Guo D, Nichol JL. Gernsheimer TB, et al. Among authors: aledort lm. J Thromb Haemost. 2010 Jun;8(6):1372-82. doi: 10.1111/j.1538-7836.2010.03830.x. Epub 2010 Mar 3. J Thromb Haemost. 2010. PMID: 20230419 Free article. Clinical Trial.

2

AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. Bussel JB, et al. Among authors: aledort lm. N Engl J Med. 2006 Oct 19;355(16):1672-81. doi: 10.1056/NEJMoa054626. N Engl J Med. 2006. PMID: 17050891 Free article. Clinical Trial.

3

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL. Kuter DJ, et al. Among authors: aledort lm. Lancet. 2008 Feb 2;371(9610):395-403. doi: 10.1016/S0140-6736(08)60203-2. Lancet. 2008. PMID: 18242413 Clinical Trial.

4

Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies.

Aledort LM, Hayward CP, Chen MG, Nichol JL, Bussel J; ITP Study Group. Aledort LM, et al. Am J Hematol. 2004 Jul;76(3):205-13. doi: 10.1002/ajh.20104. Am J Hematol. 2004. PMID: 15224353 Free article.

5

On the treatment of hemorrhage in patients with hemophilia and associated inhibitors.

Tarantino M, Aledort L. Tarantino M, et al. Transfusion. 2001 Dec;41(12):1628-9. doi: 10.1046/j.1537-2995.2001.41121628.x. Transfusion. 2001. PMID: 11778084 No abstract available.

6

Safety of human plasma-derived clotting factor products and their role in haemostasis in patients with haemophilia: meeting report.

Tarantino M, Ma A, Aledort L. Tarantino M, et al. Haemophilia. 2007 Sep;13(5):663-9. doi: 10.1111/j.1365-2516.2007.01481.x. Haemophilia. 2007. PMID: 17880460 No abstract available.

7

Advances in clotting factor treatment for congenital hemorrhagic disorders.

Tarantino MD, Aledort LM. Tarantino MD, et al. Among authors: aledort lm. Clin Adv Hematol Oncol. 2004 Jun;2(6):363-8. Clin Adv Hematol Oncol. 2004. PMID: 16163206 Review.

8

Factor VIII replacement is still the standard of care in haemophilia A.

Aledort L, Mannucci PM, Schramm W, Tarantino M. Aledort L, et al. Blood Transfus. 2019 Nov;17(6):479-486. doi: 10.2450/2019.0211-19. Epub 2019 Dec 11. Blood Transfus. 2019. PMID: 31846611 Free PMC article. Review.

9

Safety of anti-D during pregnancy.

Cromwell C, Tarantino M, Aledort LM. Cromwell C, et al. Among authors: aledort lm. Am J Hematol. 2009 Apr;84(4):261-2. doi: 10.1002/ajh.21376. Am J Hematol. 2009. PMID: 19291729 Free article. No abstract available.

10

Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity.

Aledort LM. Aledort LM. J Thromb Haemost. 2004 Oct;2(10):1700-8. doi: 10.1111/j.1538-7836.2004.00944.x. J Thromb Haemost. 2004. PMID: 15456478 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters